Step ‐down of inhaled corticosteroids in non‐eosinophilic asthma: a prospective trial in real life

Conclusions & Clinical RelevanceWithdrawing or reducing the dose of ICS is feasible in two thirds of non‐eosinophilic asthmatics irrespective of baseline asthma control. An elevated blood eosinophil count may predict the failure to stop ICS.This article is protected by copyright. All rights reserved.

Source: Clinical and Experimental Allergy - January 31, 2018 Category: Allergy & Immunology Authors: Sophie Demarche, Florence Schleich, Monique Henket, Virginie Paulus, Renaud Louis, Thierry Van Hees Tags: Original Article ‐Asthma and Rhinitis Source Type: research